The objetive of this study was to evaluate the anti HVC prevalence in different high risk groups. Subjects and Methods: 131 patients considered as high risk groups were selected:a)69 with hepatic disease (HD,34 boys, r:1m-18y);b)23 with hemato-oncologic disease (H-O, 13 boys, r:2.5...
Antibodies to hepatitis-C (HCV-Abs) in high risk groupsPersistent dry cough is one of the most common side-effects during therapy with ACE inhibitors. The frequency of cough ranges widely (from 0.2% to 15%) in different series, being higher in small studies and smaller in retrospective ...
Kandil ME, Rasheed MA, Saad NE: Hepatitis C and B viruses among some high risk groups of Egyptian children. Journal of Medical Sciences 2007, 7(8):1259-1267.Kandil, M. E., Rasheed, M. A. & Saad, N. E. Hepatitis C and B viruses among some high risk groups of Egyptian children....
. Other at-risk groups include transplant recipients, haemodialysis patients, and healthcare workers from needle-stick injuries. Tattooing andmay also be responsible for some percutaneous exposure, and in countries of high prevalence, the use of unsterilized needles for cultural rituals, medical ...
among the general population. The size of this hidden population may be substantial. A recent study estimated that of the total population of HCV-infected individuals in a high-income country, only 34% are in relatively easy to reach high-risk groups such as hemophiliac patients, HIV-infected...
Infection with the hepatitis C virus (HCV), which is independently associated with increased risk of depression, is common among MA users, possibly due to high rates of transmission risk behaviors in this cohort (eg, injection drug use). Given the prevalence of depression among HCV-infected ...
Compared to older treatments, these antivirals are superior — their efficacy is greater than 95% in most patient groups, treatment courses (8–12 weeks) are short, and the side effect profile is benign3. In addition, timely treatment of HCV in high-risk groups such as in PWIDs can ...
et al. Antibodies to hepatitis C virus. Lancet 2, 324–325 (1989). Article CAS PubMed Google Scholar Esteban, J. I. et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 2, 294–297 (1989). Article CAS PubMed Google Scholar Colombo, M. et al. Prevalence of ...
Hepatitis C virus (HCV) is a major cause of chronic liver disease globally1,2. Following acute infection, approximately 75% of people fail to clear the virus, resulting in chronic hepatitis3 with progressive hepatic fibrosis and ultimately cirrhosis, liver failure and an increased risk of hepatoce...
This survey study estimates the prevalence of current hepatitis C virus infection among adults in each US state and the District of Columbia from 2013 to